Anest. intenziv. Med. 2016;27(3):181-186

Echocardiographic examination in mitral valve diseaseEchodidaktika - postgraduální vzdělávání

J. Kunstýř1,*, H. Línková2
1 Klinika anesteziologie, resuscitace a intenzivní medicíny, VFN a 1. LF UK v Praze
2 III. interní - kardiologická klinika FNKV a 3. LF UK v Praze

Mitral valve disease plays an important role in the aetiology of cardiac failure. It may present as a serious, life-threatening condition necessitating intensive care. Echocardiography is one of the most important diagnostic tools, nowadays widely used not only by cardiologists but also by anaesthetists and intensivists. The authors present basic echocardiographic methods used in patients with mitral valve disease.

Keywords: echocardiography; mitral valve

Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kunstýř J, Línková H. Echocardiographic examination in mitral valve disease. Anest. intenziv. Med. 2016;27(3):181-186.
Download citation

References

  1. Nkomo, V. T., Gardin, J. M., Skelton, T. N. et al. Burden of valvular heart diseases: a population-based study. Lancet, 2006, 368, p. 1005-1011. Go to original source... Go to PubMed...
  2. Iung, B., Baron, G., Butchart, E. G. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart. J., 2003, 24, p. 1231-1243. Go to original source... Go to PubMed...
  3. Enriquez-Sarano, M., Akins, C. W., Vahanian, A. Mitral regurgitation. Lancet, 2009, 373, p. 1382-1394. Go to original source... Go to PubMed...
  4. Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart. J., 2012, 33, p. 2451-2496. Go to PubMed...
  5. Klein, A. A., Snell, A., Nashef, S. A., Hall, R. M., Kneeshaw, J. D., Arrowsmith, J. E. The impact of intra-operative transoesophageal echocardiography on cardiac surgical practice. Anaesthesia, 2009, 64, 9, p. 947-952. Go to original source... Go to PubMed...
  6. Lancellotti, P., Tribouilloy, C., Hagendorff, A. et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging, 2013, 14, p. 611-644. Go to original source... Go to PubMed...
  7. Lancelloti, P., Moura, L., Pierard, L. A. et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur. J. Echocardio., 2010, 11, p. 307-332. Go to original source... Go to PubMed...
  8. Marijon, E., Ou, P., Celermajer, D. S. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med., 2007, 357, p. 470-476. Go to original source... Go to PubMed...
  9. Lang, R. M., Badano, L. P., Tsang, W. et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J. Am. Soc. Echocardiogr., 2012, 25, p. 3-46. Go to original source... Go to PubMed...
  10. Baumgartner, H., Hung, J., Barmejo, J. et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur. J. Echocardio., 2009, 10, p. 1-25. Go to original source... Go to PubMed...
  11. Thomas, J. D., Weyman, A. E. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J. Am. Coll. Cardiol., 1987, 10, p. 923-929. Go to original source... Go to PubMed...
  12. Ward, C., Hancock, B. W. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br. Heart. J., 1975, 37, p. 74-78. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.